Assessing Knowledge, Beliefs and Attitudes Toward HPV Vaccination Among Parents in North West, Cameroon

NCT ID: NCT05325138

Last Updated: 2022-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

45 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-14

Study Completion Date

2023-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to assess knowledge, beliefs and attitudes of parents to young girls aged 9 to 14 years about HPV vaccines within some rural communities in the North West Region of Cameroon served by three hospitals in that area. To do this, we will conduct in-depth qualitative interviews with purposively sampled parents of girls aged 9 to 14 years, some of whom received HPV vaccine and some of whom did not. Interviews will continue until thematic saturation is reached (We anticipate a total 40 interviews). Data analysis will be done concurrently with interviews using thematic analysis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to assess knowledge, beliefs and attitudes of parents to young girls aged 9 to 14 years about HPV vaccines within some rural communities in the North West Region of Cameroon served by three hospitals in that area. Snowball sampling technique will be used. Parents of girls aged 9-14years will be included if the daughters have or have not received the HPV vaccine. Exclusion criteria include parents who are health care workers in any health institution, unwilling to provide consent, or inability to converse in English or pidgeon English. In-depth one-on-one interviews will take place using an interview guide. Interviews will be in English or pidgeon English. They will be taped and transcribed. Data will be entered into ATLAS Ti. Data analysis will be done concurrently with interviews using thematic analysis.Interviews will continue until theme saturation is reached (We anticipate a total 40 interviews).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vaccine Refusal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Parents

Parents of girls aged 9-14 years old

Interview

Intervention Type OTHER

Parents of girls aged 9-14yearsold will undergo an interview to determine their knowledge, attitudes and beliefs concerning HPV vaccination

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interview

Parents of girls aged 9-14yearsold will undergo an interview to determine their knowledge, attitudes and beliefs concerning HPV vaccination

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Parents of girls aged 9-14 years old living in Mbingo, Njinikom or Fundong health areas of northwestern Cameroon.

Exclusion Criteria

* Parents who are health care workers or working in any health institution.
* Not willing to provide informed consent
* Not able to converse in English or pidgeon English
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Merck Canada Inc.

INDUSTRY

Sponsor Role collaborator

McMaster University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lorraine Elit, MD

Professor Emeritus

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lorraine M Elit, MD MSc

Role: PRINCIPAL_INVESTIGATOR

McMaster University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mbingo Hosptial

Bamenda, North-West Region, Cameroon

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Cameroon

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lorraine M Elit, MD MSc

Role: CONTACT

9055182921

Calvin Ngalla, MSc

Role: CONTACT

+237 670 24 49 41

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Calvin Ngalla, RN

Role: primary

Glen Nbah, PhD

Role: backup

23775959629

References

Explore related publications, articles, or registry entries linked to this study.

Elit L, Tum EM, Ngalla C, Fungchwi GM, Fokom Domgue J, Nouvet E. Perceptions of Cancer in Parents of Adolescent Daughters in Northwest Cameroon. Curr Oncol. 2023 Jul 25;30(8):7167-7177. doi: 10.3390/curroncol30080519.

Reference Type DERIVED
PMID: 37623000 (View on PubMed)

Elit L, Ngalla C, Afugchwi GM, Tum E, Fokom Domgue J, Nouvet E. Assessing knowledge, attitudes and belief toward HPV vaccination of parents with children aged 9-14 years in rural communities of Northwest Cameroon: a qualitative study. BMJ Open. 2022 Nov 15;12(11):e068212. doi: 10.1136/bmjopen-2022-068212.

Reference Type DERIVED
PMID: 36379650 (View on PubMed)

Elit L, Ngalla C, Afugchwi GM, Tum E, Fokom-Domgue J, Nouvet E. Study protocol for assessing knowledge, attitudes and belief towards HPV vaccination of parents with children aged 9-14 years in rural communities of North West Cameroon: a qualitative study. BMJ Open. 2022 Aug 24;12(8):e062556. doi: 10.1136/bmjopen-2022-062556.

Reference Type DERIVED
PMID: 36002223 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

100035

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HPV Vaccine in Postpartum Women
NCT04430907 WITHDRAWN
IPV Clinical Trial - The Gambia
NCT01847872 COMPLETED PHASE4
Zambia SiVET MMR Tdap-IPV
NCT02589678 COMPLETED PHASE1/PHASE2